These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5115700)

  • 1. cis-1-(2-(p-anisidinomethyl)cyclohexyl)piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL; Szmuszkovicz J
    J Med Chem; 1971 Oct; 14(10):985-7. PubMed ID: 5115700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
    Gao LM; Yang P; Song DQ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1122-6. PubMed ID: 16496677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
    Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
    J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some novel analogues of 4-(1-Pyrrolidinyl) Piperidine and their effect on plasma glucose level.
    Mushtaq N; Saify ZS; Akhtar S; Arif M; Haider S; Saba N
    Pak J Pharm Sci; 2010 Apr; 23(2):220-3. PubMed ID: 20363703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonyliminoimidazolidines. A new class of oral hypoglycemic agents. 1. 1-[[p-[2-(acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines.
    Schweizer EH; Märki F; Lehmann C; Dietrich H
    J Med Chem; 1983 Jul; 26(7):964-70. PubMed ID: 6864736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin analogs and new oral antidiabetic drugs].
    Koivisto V
    Duodecim; 1999; 115(20):2197-202. PubMed ID: 11973922
    [No Abstract]   [Full Text] [Related]  

  • 7. Mercaptopyridinecarboxylic acids, synthesis and hypoglycemic activity.
    Blank B; DiTullio NW; Miao CK; Owings FF; Gleason JG; Ross ST; Berkoff CE; Saunders HL
    J Med Chem; 1974 Oct; 17(10):1065-71. PubMed ID: 4417798
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.
    Gupta RC; Chhipa L; Mandhare AB; Zambad SP; Chauthaiwale V; Nadkarni SS; Dutt C
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5021-5. PubMed ID: 19643608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-1-[(2-piperidinocyclohexyl)carbonyl]-piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL
    J Med Chem; 1971 Jan; 14(1):54-6. PubMed ID: 5539748
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral hypoglycemic agents: 1-(2-carboxyphenyl)pyrroles.
    Sugihara H; Matsumoto N; Hamuro Y; Kawamatsu Y
    Arzneimittelforschung; 1974 Oct; 24(10):1560-3. PubMed ID: 4479763
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure.
    Harada K; Mizukami J; Kadowaki S; Matsuda I; Watanabe T; Oe Y; Kodama Y; Aoki K; Suwa K; Fukuda S; Yata S; Inaba T
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1228-1233. PubMed ID: 29519733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 13. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of glipizide on a double-meal test in diabetic patients.
    Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
    Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents.
    Sharma R; Soman SS
    Eur J Med Chem; 2015 Jan; 90():342-50. PubMed ID: 25437620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R; Kuhla DE; Wiedermann HE; Mayhew DA
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences between oral antidiabetics].
    Bleskestad IH; Birkeland KI
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):808-9. PubMed ID: 12693123
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats.
    Das KK; Razzaghi-Asl N; Tikare SN; Di Santo R; Costi R; Messore A; Pescatori L; Crucitti GC; Jargar JG; Dhundasi SA; Saso L
    J Enzyme Inhib Med Chem; 2016; 31(1):99-105. PubMed ID: 25683079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. exo-Bicyclo(3.1.0)hexane-6-carboxylic acid and related compounds, oral hypoglycemic agents.
    Rynbrandt RH; Dutton FE; Schmidt FL
    J Med Chem; 1972 Apr; 15(4):424-6. PubMed ID: 5019566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.